Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall W A, Kanaoka Y
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9203-7. doi: 10.1073/pnas.88.20.9203.
To identify regions that are involved in the formation of the dihydropyridine receptor site of skeletal muscle L-type Ca2+ channels, the alpha 1 subunit of the channel complex was specifically labeled with the 1,4-dihydropyridine-receptor-selective photoaffinity probe [3H]diazipine. Photoaffinity-labeled regions were identified by probing labeled proteolytic fragments with several anti-peptide antibodies recognizing different segments of the alpha 1 sequence. Forty to 50% of the alpha 1-associated [3H]diazipine label was contained in the tryptic fragment between Arg-988 and Ala-1023 derived from the loop between segments S5 and S6 in domain III. This region corresponds to a portion of the channel that is believed to contribute to formation of the transmembrane pore. Twenty to 30% of the labeling occurred in a V8 protease fragment between Glu-1349 and Trp-1391. This fragment contains transmembrane segment S6 of domain IV and has previously been shown to form part of the drug receptor for phenylalkylamine Ca2+ antagonists. Our data suggest that the dihydropyridine receptor is formed by close apposition of two discontinuous regions of the alpha 1 subunit sequence in domains III and IV. In light of previous work localizing this receptor site to the extracellular surface of the lipid bilayer, it is proposed that amino acid residues at the extracellular surface in the loop connecting segments IIIS5 and IIIS6 and at the extracellular end of segment IVS6 contribute to formation of the dihydropyridine receptor site.
为了确定参与骨骼肌L型钙通道二氢吡啶受体位点形成的区域,通道复合物的α1亚基用1,4-二氢吡啶受体选择性光亲和探针[3H]二氮嗪进行特异性标记。通过用几种识别α1序列不同片段的抗肽抗体探测标记的蛋白水解片段来鉴定光亲和标记区域。40%至50%的与α1相关的[3H]二氮嗪标记物包含在源自结构域III中S5和S6片段之间环的Arg-988和Ala-1023之间的胰蛋白酶片段中。该区域对应于通道中被认为有助于跨膜孔形成的一部分。20%至30%的标记发生在Glu-1349和Trp-1391之间的V8蛋白酶片段中。该片段包含结构域IV的跨膜片段S6,并且先前已被证明形成苯烷基胺钙拮抗剂药物受体的一部分。我们的数据表明,二氢吡啶受体是由结构域III和IV中α1亚基序列的两个不连续区域紧密并列形成的。鉴于先前将该受体位点定位到脂质双分子层细胞外表面的工作,有人提出,连接IIIS5和IIIS6片段的环中的细胞外表面氨基酸残基以及IVS6片段的细胞外末端有助于二氢吡啶受体位点的形成。